Post-surgical pyoderma gangrenosum in otherwise healthy patient with history of COVID-19 Journal Article uri icon
Overview
abstract
  • There are increasing reports of autoimmune and dermatologic sequelae of COVID-19. We describe an otherwise healthy patient with recent history of serious COVID-19 infection who developed post-surgical pyoderma gangrenosum following bilateral reduction mammoplasty and was successfully treated with infliximab, mycophenolic acid, and corticosteroids. We present this case to highlight the lingering systemic proinflammatory effects of COVID-19 infection that may increase the risk of rare autoimmune complications of surgery. As a complete understanding of the long-term effects of COVID-19 is poorly understood, patients with a history of COVID-19 infection should be appropriately counseled to these possible risks when discussing surgery.

  • Link to Article
    publication date
  • 2021
  • published in
  • The breast journal  Journal
  • Research
    keywords
  • Adverse Effects
  • Autoimmune Diseases
  • COVID-19
  • Coronavirus Infections
  • Drugs and Drug Therapy
  • Surgery
  • Additional Document Info
    volume
  • 27
  • issue
  • 8